Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase
Abstract Dupilumab is a dual inhibitor of interleukin-4 and interleukin-13 and is mainly used to treat moderate-to-severe atopic dermatitis. Post-marketing safety data related to dupilumab have been accumulated, and it has been found that ocular surface diseases are closely associated with dupilumab...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/91b553811e6f4579b0f1c7d94711a33c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|